Malaria is a constant threat for nearly half of the world’s population, and people who travel to those areas are also at risk. Although the short-term side effects of prophylactic drugs are ...
In a fresh approach to blocking transmission of the malaria parasite by mosquitoes, potent antimalarial compounds that kill parasites in mosquitoes are incorporated into bed-net prototypes. Exposure ...
Scientists from Drexel University’s College of Medicine and Columbia University’s Irving Medical Center have uncovered a crucial structural feature of a key malaria drug target, known as PfATP4, and ...
Patients who are infected with malaria and dengue virus receive treatment in an isolation ward at a hospital in Pakistan. Drugs known as artemisinins have been remarkably effective in helping malaria ...
Nigerian scientists achieve a major breakthrough in malaria drug research, depositing the first crystal structure of a key ...
Patients with RA or SLE who adhere to antimalarial therapy have a lower risk for hospital admission and fewer days of hospital stay than their nonadherent peers.
The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a fresh public alert on its earlier regulatory directive discontinuing the registration and use of multi-dose ...
This activity was supported by Contract Order No. VA 36C24E18C0067 between the National Academy of Sciences and the Department of Veterans Affairs. Any opinions, findings, conclusions, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results